Register

About Lindsay Rosenwald

Lindsay Rosenwald / Basic Information

  • Gender

  • Birthdate

    04-16
  • About Lindsay Rosenwald

    Dr. Lindsay Rosenwald is a renowned entrepreneur concentrating in the areas of medical research and biotechnology. In the last 20 years, Dr. Rosenwald has gained considerable acclaim as an asset manager, venture capitalist and investor.

    Under the guidance of Dr. Lindsay Rosenwald, a team of clinical professionals developed TRISENOX® for leukemia, an FDA-approved medication that has saved the lives of thousands of leukemia sufferers. TRISENOX is now sold by Teva, one of the world’s largest pharmaceutical companies.

    Among his most recent achievements, Dr. Lindsay Rosenwald developed his company, Cougar Biotechnology, into a premier medical research firm with a global reach. In 2009, Cougar Biotechnology was sold to Johnson & Johnson for nearly $1 billion and now operates in conjunction with Ortho Biotech Oncology Research & Development.

    Dr. Lindsay Rosenwald co-founded Investment Partnership. Committed to investing in and identifying key innovations in health care and life science, the team at Investment Partnership hopes to change how diseases are diagnosed while improving patient care.

    As one of the most successful and prolific investors in biotechnology, Dr. Rosenwald has given back to the medical community through a number of charitable causes. He developed and directs his own philanthropic foundation, which donates millions of dollars to potentially groundbreaking efforts in medical research.

    An internationally-recognized leader in biotechnology financing, Dr. Rosenwald has been ranked at the top of Genetic Engineering & Biotechnology News’ list of Molecular Millionaires. He is a former member of the Columbia Presbyterian Health Sciences Advisory Council.

    Before dedicating his career to medical research, Dr. Lindsay Rosenwald worked both as a physician and a financial analyst on Wall Street. He received a Doctorate of Medicine from the Temple University School of Medicine, as well as a Bachelor of Science in finance from Penn State.
  • Languages Spoken

    English

Lindsay Rosenwald / Contact Information

Lindsay Rosenwald / Education

Connections

    No connections yet

Groups

No joined groups.
Lindsay Rosenwald
Lindsay Rosenwald - We have a better diagnostic technology today - way more advanced than even 10 years ago.
- 7 months ago
  • Lindsay Rosenwald Member since
    Friday, 30 August 2013 09:29
  • Lindsay Rosenwald Last online
    6 months ago
  • Lindsay Rosenwald Profile views
    4,759 views

About Lindsay Rosenwald

Lindsay Rosenwald / Basic Information

  • Gender

  • Birthdate

    04-16
  • About Lindsay Rosenwald

    Dr. Lindsay Rosenwald is a renowned entrepreneur concentrating in the areas of medical research and biotechnology. In the last 20 years, Dr. Rosenwald has gained considerable acclaim as an asset manager, venture capitalist and investor.

    Under the guidance of Dr. Lindsay Rosenwald, a team of clinical professionals developed TRISENOX® for leukemia, an FDA-approved medication that has saved the lives of thousands of leukemia sufferers. TRISENOX is now sold by Teva, one of the world’s largest pharmaceutical companies.

    Among his most recent achievements, Dr. Lindsay Rosenwald developed his company, Cougar Biotechnology, into a premier medical research firm with a global reach. In 2009, Cougar Biotechnology was sold to Johnson & Johnson for nearly $1 billion and now operates in conjunction with Ortho Biotech Oncology Research & Development.

    Dr. Lindsay Rosenwald co-founded Investment Partnership. Committed to investing in and identifying key innovations in health care and life science, the team at Investment Partnership hopes to change how diseases are diagnosed while improving patient care.

    As one of the most successful and prolific investors in biotechnology, Dr. Rosenwald has given back to the medical community through a number of charitable causes. He developed and directs his own philanthropic foundation, which donates millions of dollars to potentially groundbreaking efforts in medical research.

    An internationally-recognized leader in biotechnology financing, Dr. Rosenwald has been ranked at the top of Genetic Engineering & Biotechnology News’ list of Molecular Millionaires. He is a former member of the Columbia Presbyterian Health Sciences Advisory Council.

    Before dedicating his career to medical research, Dr. Lindsay Rosenwald worked both as a physician and a financial analyst on Wall Street. He received a Doctorate of Medicine from the Temple University School of Medicine, as well as a Bachelor of Science in finance from Penn State.
  • Languages Spoken

    English

Lindsay Rosenwald / Contact Information

Lindsay Rosenwald / Education

Connections

    No connections yet

Groups

No joined groups.

Popular Members

Lindsay RosenwaldDr. Hicham RibaMarla AhlgrimmJames CullemRick DoverSophia Wong YOR Health